Deregulated MYC expression induces dependence upon AMPK-related kinase 5

Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
Nature (Impact Factor: 41.46). 03/2012; 483(7391):608-12. DOI: 10.1038/nature10927
Source: PubMed


Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumours, yet strategies to exploit this for a rational tumour therapy are scarce. MYC promotes cell growth and proliferation, and alters cellular metabolism to enhance the provision of precursors for phospholipids and cellular macromolecules. Here we show in human and murine cell lines that oncogenic levels of MYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival. ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signalling pathway. ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metabolism. Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence. Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumour cells that express deregulated MYC.

Download full-text


Available from: Daniel J Murphy
  • Source
    • "Proteome analysis was performed as described by us previously (Liu et al., 2012). Briefly: to achieve quantitative proteome data, a ''heavy'' proteome reference was spiked in equal amounts in every sample. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Graphical Abstract Highlights d The metabolic profile of embryonic stem cell changes within hours of differentiation d Glycolytic production of acetyl-CoA promotes histone acetylation during pluripotency d Glycolysis inhibition leads to deacetylation and differentiation of pluripotent cells d Pharmacologic modulation of acetyl-CoA regulates pluripotency
    Full-text · Article · Mar 2015 · Cell metabolism
  • Source
    • "Knockdown of NUAK1 prevents tumorigenesis in MYC-driven mouse models of HCC. Depletion of NUAK1 after tumorigenesis also suppresses tumor growth and provides a survival advantage to the mice (P < 0.01) (Liu et al., 2012). "

    Preview · Article · Oct 2014
  • Source
    • "Surprisingly, we observed that 2DG does not directly block glycolysis but rather interferes with phosphate and thus ATP metabolism. In summary, we show that the pSIRM approach facilitates the identification of metabolic dysregulation directly, without the need to separately calculate metabolic fluxes [18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Cellular metabolism is highly dynamic and continuously adjusts to the physiological program of the cell. The regulation of metabolism appears at all biological levels: (post-) transcriptional, (post-) translational, and allosteric. This regulatory information is expressed in the metabolome, but in a complex manner. To decode such complex information, new methods are needed in order to facilitate dynamic metabolic characterization at high resolution. Results Here, we describe pulsed stable isotope-resolved metabolomics (pSIRM) as a tool for the dynamic metabolic characterization of cellular metabolism. We have adapted gas chromatography-coupled mass spectrometric methods for metabolomic profiling and stable isotope-resolved metabolomics. In addition, we have improved robustness and reproducibility and implemented a strategy for the absolute quantification of metabolites. Conclusions By way of examples, we have applied this methodology to characterize central carbon metabolism of a panel of cancer cell lines and to determine the mode of metabolic inhibition of glycolytic inhibitors in times ranging from minutes to hours. Using pSIRM, we observed that 2-deoxyglucose is a metabolic inhibitor, but does not directly act on the glycolytic cascade.
    Full-text · Article · Jun 2014
Show more